ClinicalTrials.Veeva

Menu

Supportive Effects of Craniosacral Therapy for Female Patients With Breast Cancer and Their Partners (CRANIO4US)

U

Universität Duisburg-Essen

Status

Active, not recruiting

Conditions

Breast Cancer
Complementary Therapies

Treatments

Procedure: Treatment as usal / wait list
Procedure: Craniosacral self-help group training
Procedure: Craniosacral therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT04319510
2019402

Details and patient eligibility

About

Craniosacral Therapy (CST) is a non-manipulative, very gentle, manual treatment method that aims to release restrictions of the fasciae and regulate the arousal of the sympathetic nervous system, which is often increased in chronically ill patients. Initial randomized trials support CST's efficacy and effectiveness in reducing symptoms of patients with psychosomatic and chronic pain disorders. To date, there is no trial investigating the effectiveness of CST as a supportive strategy for enhancing cancer-related quality of life in women with breast cancer. In clinical practice, therapists also report alleviating as well as regulating effects of simple CST self-help techniques, offered to patients within a group concept.

Within the recent study, a CST treatment and self-help protocol for women after curative therapy of breast cancer was developed and shall be tested against a waiting list control group. The first group will receive 24 units of CST treatment in a 1:1 setting with a certified craniosacral therapist over 12 weeks. The second group will receive 24 units of group training in CST self-help techniques offered by a certified craniosacral therapist over 12 weeks. They will be reassessed after 12 and 26 weeks (6 months) after randomization. The third group will wait for 26 weeks and will receive no specific study intervention. After 26 weeks patients of the third group were offered to take part in two individual CST interventions and the CST self-help training. For all groups, treatment as usual is allowed.

Enrollment

102 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Breast cancer (stage I-III) survivors after finishing curative chemotherapy and/or radiation
  • Impaired breast caner-related quality of life (< 112,8 points on the FACT-B)

Exclusion criteria

  • Planned surgery, adjuvant therapy (chemotherapy and/or radtiation), or rehabilitation during the study period
  • Pregnancy
  • Simultaneous participation in other clinical trials

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

102 participants in 3 patient groups

Craniosacral therapy
Experimental group
Description:
24 CST units à 45 minutes over 12 weeks. Follow-up assessment 6 months after randomization.
Treatment:
Procedure: Craniosacral therapy
Craniosacral self-help group training
Experimental group
Description:
24 CST units à 45 minutes over 12 weeks. Follow-up assessment 6 months after randomization.
Treatment:
Procedure: Craniosacral self-help group training
Treatment as usual / wait list control
Other group
Description:
Waiting period of six months.
Treatment:
Procedure: Treatment as usal / wait list

Trial contacts and locations

3

Loading...

Central trial contact

Holger Cramer, PhD; Heidemarie Haller, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems